lunes, 25 de mayo de 2020

Long-Acting Injectable Drug Prevents HIV Among Men Who Have Sex with Men and Transgender Women | NIH: National Institute of Allergy and Infectious Diseases

Long-Acting Injectable Drug Prevents HIV Among Men Who Have Sex with Men and Transgender Women | NIH: National Institute of Allergy and Infectious Diseases

NIH: National Institute of Allergy and Infectious Diseases Logo

Long-Acting Injectable Drug Prevents HIV Among Men Who Have Sex with Men and Transgender Women

NIH Study is First Large Trial to Find Long-Acting HIV Prevention Highly Effective--Companion Study in Women Is Ongoing

May 18, 2020

No hay comentarios:

Publicar un comentario